Disclosure

Close Concerns operates a subscription news service that has a strict policy of editorial independence. Our subscribers are technology and therapy manufacturers, hospitals, and other nonprofits, including the following organizations:

A. Menarini Diagnostics
AACE
AADE
Abbott Diabetes Care
ADA
Adocia
Agamatrix Inc.
Air Liquide Sante International
Arkray USA, Inc.
Ascensia Diabetes Care
AstraZeneca Pharmaceuticals
Baird
Bayer AG
BCG
BectonDickinson
Bigfoot Biomedical
Biocorp.
Biolinq
Blue Arrow
BMO
Boehringer Ingelheim
BoydSense, Inc.
Byram Healthcare
Capillary Biomedical
CeQur
Common Sensing
Companion Medical
Covance Inc
Creighton University
Dario Health Corp
DexCom
Diasome Pharmaceuticals
Eli Lilly
Enanta
Endocrine Society, The
Eoflow, Co., Ltd.
Fidelity Management & Research
Glooko, Inc.
GlySens Inc.
Glytec
Harvard School of Engineering & Applied Sciences
Helmsley Charitable Trust
Indigo Medical
Insulet
Intarcia Therapeutics
Intuity Medical
IQVIA
Jaeb Center
Janssen Pharmaceuticals,Inc
JDRF
Joslin Diabetes Center
Lexicon Pharmaceuticals
Lifescan
Livongo Health
Locemia Solutions ULC
Lucisano Consulting
MannKind Corp.
McKinsey & Co.
Med Angel BV
Medscape LLC
Medtronic
Merck Sharpe & Domne
Metavant Sciences
Metronom Health
Modular Medical Inc.
Mundi Pharma
Nestle Health Sciences
Novo Nordisk
Onduo LLC
One Drop
Oregon Health Sciences University
Park Nicollet Health Services
Pfizer
PHC
Physiologic Devices
Profil Institut Fur Stoffwechslforschung
ProSciento
Roche
Sanofi US Services
Science 37, Inc.
Senseonics, Incorporated
Servier Monde/Les Laboratoires Servier
Stifel Financial Corp
Tandem Diabetes Care
Thermalin Diabetes
Tidepool Project
Tolerion, Inc.
UBS Global Asset Management
UnitedHealth Group
T1D Exchange
Unomedical
Valeritas, LLC
Verily
Viacyte, Inc.
Virgo Health
Voluntis
vTv Therapeutics
WellDoc
West Pharmaceutical
Xeris Pharmaceuticals, Inc.
Ypsomed AG
Zafgen
Zealand Pharma